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Abstract
Background: Exaggerated vasoconstriction plays a very important role in the hypertension, a major component of
metabolic syndrome (MetS). In the current work, the potential protective effect of methanol extract of fruit hulls of
Garcinia mangostana L. on the exaggerated vasoconstriction in MetS has been investigated. In addition, the
bioactive fraction and compounds as well as the possible mechanism of action have been illustrated.
Methods: The effect of methanol extract of G. mangostana (GMT) fruit hulls on the vascular reactivity of aorta
isolated from animals with MetS was investigated through bioassay-guided fractionation procedures. GMT was
partitioned with chloroform (I) and the remaining mother liquor was fractionated on a Diaion HP-20 with H2O,
50 and 100 % methanol to give fractions II, III, and IV, respectively. The effect of total extract (GMT), bioactive
fraction and the bioactive compounds on the vasoconstriction were examined in aortae isolated from animals
with MetS by incubation for 30 min before exposing aortae to cumulative concentrations of phenylephrine (PE).
The direct relaxant effect was also examined by adding cumulative concentrations of the bioactive fraction and its
bioactive compounds to PE precontracted vessels. In addition, aortic nitric oxide (NO) and reactive oxygen species
(ROS) production was investigated.
Results: Bioassay-guided fractionation of GMT revealed isolation of garcimangosone D (1), aromadendrin-8-C-β-D-
glucopyranoside (2), 2,4,3′-trihydroxy benzophenone-6-O-β-D-glucopyranoside (3), maclurin-6-O-β-D-glucopyranoside
(rhodanthenone) (4), epicatechin (5), and 2,3′,4,5′,6-pentahydroxy benzophenone (6). Only compounds 2, 4, and 5
significantly alleviated the exaggerated vasoconstriction of MetS aortae and in the same time showed significant
vasodilation of PE pre-contracted aortae. To further illustrate the mechanism of action, the observed vasodilation was
completely blocked by the nitric oxide (NO) synthase inhibitor, Nω-nitro-L-arginine methyl ester hydrochloride and
inhibited by guanylate cyclase inhibitor, methylene blue. However, vasodilation was not affected by the potassium
channel blocker, tetraethylammonium or the cyclooxygenase inhibitor, indomethacin. In addition, compounds 2, 4,
and 5 stimulated NO generation from isolated aortae to levels comparable with acetylcholine. Furthermore, 4 and 5
inhibited reactive oxygen species generation in MetS aortae.
Conclusion: The phenolic compounds 2, 4, and 5 ameliorated the exaggerated vasoconstriction in MetS aortae
through vasodilatation-NO generation mechanism.
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Background
Metabolic syndrome (MetS) is considered as a major
worldwide problem that is characterized by hyperten-
sion, hyperinsulinemia and obesity. This syndrome is
affecting more than quarter of the world population, due
to lack of physical activity and high calorie nutrition [1].
People affected by metabolic syndrome are in high risk
of developing cardiovascular complications [2]. This is
attributed to the effect of hyperglycaemia and oxidative
stress on vascular biology [3]. Vascular endothelia play a
major role in maintaining cardiovascular homeostasis
through releasing a number of mediators that regulate
platelet aggregation, coagulation, fibrinolysis, and vascu-
lar tone [4]. Hyperglycemia causes vascular damage in
different cells of vascular cell wall leading to endothelial
dysfunction and reduction in NO production that give
rise to vasoconstriction [5]. Therefore, MetS is associ-
ated with changes in vascular responsiveness to vasocon-
strictors and vasodilators. The changes in vascular
reactivity are responsible for the development of many
vascular complications [6]. Consequently, searching for
drugs that have the ability to overcome endothelial
dysfunction will help in the treatment of diabetic
complications.
Herbal drugs are commonly used worldwide due to its
high efficacy, few side effects, and relatively low cost.
Many plants and its active constituents have been re-
ported for their antidiabetic activity [7]. Some phenolic
compounds were reported to have relaxant effect on
vasoconstriction [8, 9]. Mangosteen is used traditionally
throughout Southeast Asia for preventing some diseases
including hypertension,, obesity, and diabetic complica-
tions [10]. Moreover, it revealed an antidiabetic effect
through α-glucosidase inhibition [11]. Also, the fruit
causes a decrease in body mass index (BMI) indicating
its possible anti-obesity effect. However, the fruit juice
has shown anti-obesity potential, accordingly, more de-
tailed studies are required to confirm its efficacy in the
prevention and/or treatment of obesity and diabetes
[10]. In addition, mangosteen showed a remarkable
vaso-relaxant effect on isolated rat aorta [12] and
inhibited advanced glycation end products (AGEs)
formation at the levels of Amadori product and pro-
tein aggregation through saving protein thiol [13].
The phytochemical screening of G. mangostana re-
vealed the presence of phenolic compounds, including
prenylated xanthones, benzophenones, flavonoids, and
anthocyanins [13–15].
Current study aims at the examination of the potential
protective effect of methanol extract of G. mangostana
(GMT) fruit hulls on the exaggerated vasoconstriction in
MetS aortae. In addition; the main bioactive fraction and




Electron spray ionization mass (ESIMS) was recorded on
an LCQ DECA mass spectrometer (Thermo Finnigan,
Bremen, Germany) coupled with an Agilent 1100 HPLC
using photodiode array detector. NMR spectra were re-
corded on a Bruker DRX-400 MHz Ultrashield spec-
trometer (Bruker BioSpin, Billerica, MA, USA). CD3OD
was used as a solvent, and TMS as the internal refer-
ence. Pre-coated thin layer chromatography (TLC)
plates; silica gel 60 F254 were purchased from Merck,
Darmstadt, Germany. Silica gel 60 (70–230 mesh),
Diaion HP-20, and polyamide 6 (Merck, Darmstadt,
Germany) were used for different column chromato-
graphic procedures.
Chemicals
Compounds used for the biological study; 4-Amino-5-
methylamino-2′,7′-difluorofluorescein diacetate (DAF-
FM) and 2′,7′-dichlorofluorescein diacetate (DCF) were
obtained from Molecular Probes, New York, USA. In
addition, methylene blue (MB), Nω-Nitro-L-arginine
methyl ester hydrochloride (L-NAME), indomethacin
(INDO), tetraethylammonium chloride (TEA), and
phenylephrine (PE) were obtained from Sigma-Aldrich
(Munich, Germany). Ultrapure deionized water was used
for dissolving all chemicals except DAF-FM, DCF, and
INDO, which were dissolved in dimethylsulphoxide
(DMSO). Final DMSO concentration in the assay media
did not exceed 0.1 %.
Plant material
G. mangostana fruits were obtained from the market in
Kingdom Saudi Arabia in December 2014. The fruits
were air dried and a voucher specimen was kept in the
herbarium of Faculty of Pharmacy, King Abdulaziz Uni-
versity (no. GM1424). The identity of the plant was
kindly authenticated by Dr. Emad Al-Sharif, Associate
Professor of Plant Ecology, Dept. of Biology, Faculty of
Science & Arts, Khulais, King Abdulaziz University,
Saudi Arabia.
Extraction and isolation
The dried pulverised G. mangostana fruit hulls (500 gm)
were exhaustively extracted with methanol using Ultra-
turrax. The collected methanol extracts were evaporated
under vacuum to produce a brown residue of the total
methanol extract (GMT, 20 g). GMT was suspended in
water (500 mL) and fractionated with chloroform to pro-
duce a CHCl3- soluble fraction (Fr I). The remaining
aqeous layer was concentrated and applied to a Diaion
HP-20 column (6 × 110 cm, 250 g) and eluted succes-
sively with H2O, 50 % MeOH and 100 % MeOH (1 L,
each). The collected fractions were separately evaporated
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under vaccum to obtain fractions II (2 gm), III (7 gm)
and IV (4 gm), respectively [13]. Part of fraction III (FR.
III) was chromatographed on polyamide column (6 ×
100 cm, 250 g) and eluted with H2O and increasing
amounts of MeOH until pure MeOH, the obtained frac-
tions were pooled into four main subfractions (A-D)
based on TLC investigations. Subfraction A (10–20 %
MeOH) was purified on a silica gel column (25 × 2 cm,
50 g) using CHCl3:MeOH (9.5:0.5, v/v) to give com-
pounds 1 (14 mg) and 2 (125 mg). Subfraction B (30 %
MeOH) was chromatographed on silica gel column
(25 × 2 cm, 50 g) and eluted with CHCl3:MeOH (9.5:0.5,
v/v) to afford compounds 3 (32 mg) and 4 (50 mg). Sub-
fraction C (40–60 % MeOH) was applied to silica gel
column (25 × 2 cm, 50 g) using CHCl3:MeOH (9:1, v/v)
to yield 5 (150 mg). Finally, Silica gel column (25 × 2 cm,
50 g) of subfraction D (70–100 % MeOH) using
CHCl3:MeOH (8:2, v/v) gave 6 (30 mg).
Animals
The current study was conducted using 72 male Wistar
rats (6–8 weeks old). They were supplied by the Animal
house, King Abdulaziz University, Jeddah, Saudi Arabia.
Animals were acclimatized in animal facility for seven
days before the experiment. They were maintained on a
12-h light–dark cycle, and stable temperature (22 ± 2
oC). Experimental protocol was ethically approved by
the Unit of Biomedical Ethics, Faculty of Medicine, King
Abdulaziz University (Reference # 329–16).
The metabolic syndrome (MetS) was induced in rats
by adding fructose (10 %) to every day drinking water
and salt (3 %) to the diet for 12 weeks while control rats
received standard diet. The induction of MetS was con-
firmed by a stable hyperinsulinemia (2.5–3.5 ng/dL) after
12 weeks of high fructose/high salt diet. This protocol
was found effective in inducing vascular complications
associated with MetS as indicated in previous work from
our laboratories [16]. Animals were killed by decapita-
tion and the thoracic aorta was carefully excised and
washed with ice-cold Krebs-Henseleit buffer (KHB; NaCl
118.1, KCl 4.69, KH2PO4 1.2, NaHCO3 25.0, glucose
11.7, MgSO4 0.5, and CaCl2 2.5 mM). The aorta was cut
into rings (~3 mm length) after cleaning from fat and
connective tissue. A glucose meter (ACCU-CHEK,
Roche, Mannheim, Germany) was used to measure glu-
cose level from tail blood. An immunosorbent assay
(ELISA, Millipore, Billerica, MA, USA) with anti-rat in-
sulin monoclonal antibodies was used to measure serum
insulin.
Vascular reactivity
Vascular reactivity of the isolated aortae was performed
using the isolated artery techniques as previously de-
scribed [17–20]. In brief, aortae isolated from MetS
animals were incubated with the vehicle (0.1 % DMSO)
or different concentrations of GMT (10–100 μg/mL),
fractions (I, III, IV) (1–10 μg/mL) or isolated com-
pounds (all at 10–100 μM) for 30 min before studying
the vasoconstriction responses to the standard vasocon-
strictor phenylephrine (PE). For studying the contractile
responsiveness of aortae, increments in tension to cumu-
lative additions of PE (10−9 to 10−5 M) were recorded.
Direct vasodilatation
A set of experiments were carried out for investigating
the direct vasodilation effect of GMT, fractions (I, III,
and IV), or isolated compounds 1–6. In these experi-
ments, cumulative concentrations of GMT or fractions
(I, III, and IV) all at concentrations (1–100 μg/mL) or
isolated compounds 1–6 (Conc. 10–100 μM) were
added to the organ bath, containing isolated aortae pre-
contracted with PE (10 μM) and the decreases in tension
was recorded. Final vehicle concentration (0.4 % DMSO)
did not show any effect on PE (10 μM) precontraction
in our preliminary data. In other sets of experiments, L-
NAME (100 μM), MB (5 μM), TEA (10 mM), INDO
(5 μM) or the vehicle (0.1 % DMSO) were added 30 min
before investigating the direct vasodilator effect of Fr. III
and compounds 2, 4, and 5 as above.
NO generation
The NO generation from isolated aorta was investigated
using the fluorescence probes 4-amino-5-methylamino-
2′,7′-difluorofluorescein diacetate (DAF-FM) as in pre-
vious work from our laboratories [9, 21–23] with some
modifications. Briefly, isolated aortic rings (~3 mm
length) was added to 96 well black plate wells containing
110 μL saline and 2.5 μM DAF-FM with or without
acetylcholine (100 μM), Fr. III (1 μg/mL) or com-
pounds 2, 4, and 5 (Conc. 100 μM) for 3 min (incu-
bated at 37 °C). At the end, 90 μL volumes were
transferred into new wells and the fluorescence intensity
(λex = 485, λex = 525) were measured using monochrom-
ator SpectraMax® M3 plate reader (Molecular devices,
California, USA). The fluorescence intensity of the DAF-
FM plus acetylcholine, Fr. III or any of the compounds
before addition of aortic rings were recorded and sub-
tracted to avoid any interference from the tested substance
own fluorescence.
ROS generation
The reactive oxygen species (ROS) generation from iso-
lated aortic rings (~3 mm length) was investigated using
the fluorescence probes 2′,7′-dichlorofluorescein diace-
tate (DCF) as previously described [24, 25] with some
modifications. Briefly, isolated aortae were added to 96
well black plate wells, containing 110 μL volumes of
saline and 2.5 μM DCF with or without Fr. III (1 μg/mL)
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or compounds 2, 4, and 5 (Conc. 100 μM) for 30 min at
37 °C. At the end 90 μL volumes were transferred to
new wells and the fluorescence intensity were measured
(λex = 485, λex = 525) using monochromator Spectra-
Max® M3 plate reader. The fluorescence intensity of the
DCF plus tested substances before addition of aortic
rings were recorded and subtracted to avoid any interfer-
ence from the tested substance own fluorescence.
Statistical analysis
Values are expressed as mean ± SEM and N = 6. Statistical
analysis was carried out by the one or two (as indicated in
figure legends) way analysis of variance (ANOVA)
followed by Dunnett’s post hoc test using the statistical
software Prism 5® (Graphpad, CA, USA). Probability levels
less than 0.05 were considered statistically significant.
Results
Metabolic syndrome characteristics
Addition of fructose (10 %) to every day drinking water
and salt (3 %) to the diet for 12 weeks led to a significant
increase in body weight, fasting blood glucose, insulin
and mean arterial blood pressure compared with control
rats (Table 1).
Effect of GMT and fractions
Effect on exaggerated vasoconstriction
Aortae isolated from MetS animals showed exaggerated
vasoconstriction responses to PE compared to control
group (Fig. 1a). Incubation of aortae isolated from MetS
animals for 30 min with GMT at final concentrations of
10, 30, and 100 μg/mL significantly alleviated the exag-
gerated vasoconstriction in a concentration dependent
manner (Fig. 1a).
Direct vasodilation
In search for the bioactive fraction, Fig. 1b showed that
the addition of cumulative concentrations (1–100 μg/mL)
of GMT as well as fractions (I, III, and IV) to the organ
bath led to a concentration dependent vasodilation of iso-
lated aortae pre-contracted with PE (10 μM). Fr. III pos-
sessed the main active compounds as it produced the
strongest relaxation of PE pre-contracted aortae (Fig. 1b).
Effect of Fr. III and isolated compounds
Phytochemical investigation
Bio-guided fractionation revealed a high bioactivity of Fr.
III. While, Fr. II was found to be free sugars and exhibited
no polyphenolic characters, by tracing on TLC and PC
using AlCl3 and FeCl3 as well as p-anisaldehyde:H2SO4
spray reagents. Phytochemical investigation of Fr. III re-
sulted in the isolation of six major metabolites (Fig. 2). The
structures of isolated compounds were identified based on
comparison of their spectral data (1D and 2D NMR) with
those previously published and confirmed through co-
chromatography with authentic samples as garcimangosone
D (1) [26], aromadendrin-8-C-β-D-glucopyranoside (2)
[27], 2,4,3′-trihydroxy benzophenone-6-O-β-D-glucopyra-
noside (3) [28], maclurin-6-O-β-D-glucopyranoside
(rhodanthenone) (4) [28], epicatechin (5) [29], and
2,3′,4,5′,6-pentahydroxy benzophenone (6) [30] (Additional
file 1: Figures S1-S12 and Tables S1 & S2).
Effect on exaggerated vasoconstriction
The responsibility of Fr. III and compounds 2, 4, and 5
to alleviate exaggerated vasoconstriction produced by
the total extract was confirmed. Figure 3 showed that in-
cubation with only Fr. III (1, 3, and 10 μg/mL) alleviated
the exaggerated vasoconstriction of MetS aortae (Fig. 3a).
Similar alleviations of MetS aortae exaggerated response
were observed after 30 min incubation with 10, 30, and
100 μM of 2 (Fig. 3b), 4 (Fig. 3c), and 5 (Fig. 3d),
respectively.
Direct vasodilation
Addition of cumulative concentrations of Fr. III (1–
10 μg/mL) to the organ bath led to a concentration
dependent vasodilation of PE pre-contracted aortae
(Figs. 4a and 5a). Similarly, addition of cumulative concen-
trations of compounds 2, 4, and 5 (Conc. 10–100 μM) to
the organ bath led to a concentration dependent vasodila-
tion (Fig. 5b). However, 1, 3, and 6 had no significant
vasodilation (Fig. 5c).
Thirty minutes pre-incubation with the nitric oxide
synthase inhibitor Nω-nitro-L-arginine methyl ester
hydrochloride (L-NAME, 100 μM) before the cumulative
addition of Fr. III completely blocked Fr. III vasodilation
(Figs. 4b and 5a). Pre-incubation with the guanylate cy-
clase inhibitor methylene blue (MB, 5 μM), partially
inhibited the produced vasodilation (Figs. 4c and 5a).
While, pre-incubation with the calcium-activated potas-
sium channels blocker tetraethylammonium chloride
(TEA, 10 mM), or the cyclooxygenase inhibitor indo-
methacin (INDO, 5 μM) did not significantly affect Fr.
III-induced vasodilation (Fig. 5a). Similarly, thirty
minutes pre-incubation with L-NAME significantly
inhibited the produced vasodilation of compounds 2, 4,
and 5 (Fig. 5b).
Table 1 Effect of adding fructose (10 %) to every day drinking
water and salt (3 %) to the diet for 12 weeks on the increase in
body weight, blood glucose, serum insulin and mean arterial









Control 32.46 ± 5.5 74.4 ± 3.1 0.72 ± 0.08 120.8 ± 1.7
MetS 128.6 ± 33.7* 112.8 ± 5.3* 2.79 ± 0.41* 145.0 ± 2.2*
Values are expressed as the mean ± SEM; N = 8 animals; *P < 0.05, compared
with the corresponding control group values using Unpaired t test
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Nitric oxide generation
Inserting isolated aortae in media, containing Fr. III (10 μg/
mL) produced significant NO generation compared with
control. Similarly, compounds 2, 4, and 5 (Conc. 100 μM)
significantly generated NO from isolated aortae compared
with control to a level similar to acetylcholine (Fig. 6).
Effect on ROS generation
Overproduction of ROS was observed from aortae
isolated from MetS animals compared to control.
Thirty minutes pre-incubation with Fr. III (10 μg/mL)
significantly inhibited ROS generation from MetS aor-
tae (p < 0.01). Similarly, compounds 4 and 5 (Conc.
Fig. 1 Effect of thirty minutes incubation of different concentrations (10–100 μg/ml) of the mangosten total extract (GMT) on the responsiveness
to phenylephrine of aortae isolated from fructose and salt- induced metabolic syndrome (MetS, for 12 weeks). *P < 0.05, compared with the
corresponding control values; #P < 0.05, compared with the corresponding MetS values; by two Way ANOVA and Dunnett’s post hoc test”. (a)
and: Effect of cumulative addition (1–100 μg/ml) of GMT and its fractions on phenylephrine pre-contracted MetS aortae. *P < 0.05, compared with
the corresponding time control values; by Tow Way ANOVA and Dunnett’s post hoc test”. (b). *P < 0.05, compared with the corresponding control
values; #P < 0.05, compared with the corresponding MetS values; by Tow Way ANOVA and Dunnett’s post hoc test
Fig. 2 Chemical structures for compounds isolated from G. mangostana
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100 μM) significantly inhibited ROS generation from
MetS aortae. However, compound 2 did not affect
ROS generation from MetS aortae (Fig. 7).
Discussion
The current study is the first report on the protective
effect of G. mangostana (GM) on exaggerated vasocon-
striction in MetS. A multidisciplinary approach was
employed for studying vasoconstriction, dilatation, NO,
and ROS production to find out the active metabolite in
GM through bioassay-guided process.
It is widely accepted that development of hyperten-
sion in normal persons and in MetS is dependent
greatly on changes in vascular reactivity. Exaggerated
vasoconstriction and or impaired vasodilation are
usually correlated with increase in blood pressure
[31, 32]. In the current study, isolated aortae from
MetS animals showed overstated response upon
exposure to PE which is in agreement with previous
reports showing that different vasoconstrictors pro-
duced exaggerated response in MetS [33, 34]. Several
reports revealed the role of phenolic compounds in
alleviating the exaggerated vasoconstriction and
hence alleviating hypertension in MetS [8, 9]. GM is
known for its high content of phenolic constituents
such as xanhtone, flavonoids and benzophenones and
its anti-diabetic activity [15].
In the present study, GMT significantly alleviated
the exaggerated vasoconstriction in MetS aortae in a
concentration dependent manner. This effect seemed
to be mediated by direct vasodilatation activity as
indicated by the data presented here. The bioassay-
guided fractionation procedures revealed that Fr. III
was mainly responsible for the observed activity
while fraction I (xanthone rich fraction) showed
weak activity. Chemical investigation of the bioactive
fraction resulted in isolation of six major metabolites
(1–6). Only compounds 2, 4, and 5 showed signifi-
cant vasodilation suggesting that they are the main
active metabolites responsible for the observed
vasodilation in Fr. III and hence the total extract of
GM.
The observed vasodilation produced by Fr III as
well as compounds 2, 4, and 5 seemed to be
Fig. 3 Effect of 30 min in vitro incubation with Fr. III (a) and compounds 2 (b), 4 (c) , and 5 (d) on the responsiveness to PE of aortae isolated
from fructose and salt-induced metabolic syndrome (MetS, for 12 weeks). *P < 0.05, compared with the corresponding control values; #P < 0.05,
compared with the corresponding MetS values; by Tow Way ANOVA and Dunnett’s post hoc test
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through stimulating NO generation from the vascu-
lature as Fr. III relaxation was completely blocked by
the nitric oxide synthase inhibitor and partially
inhibited by guanylate cyclase inhibitor. Meanwhile,
it was not affected by the calcium-activated potas-
sium channels blocker or the cyclooxygenase inhibi-
tor. The vasorelaxation responses of Fr. III are
almost similar to the responses of compounds 2, 4,
Fig. 4 Representative charts for the effect of cumulative addition of Fr. III (1–10 μg/mL) in absence (a) or presence of Nω-Nitro-L-arginine methyl
ester hydrochloride (L-NAME, 100 μM, b) or, methylene blue (MB, 5 μM, c) on phenylephrine (PE 10 μM) pre-contracted aortae isolated
from normal Wistar rats. L-NAME, MB or the vehicle were added 30 min before investigating the vasodilator effect
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and 5. The reason may be competition between the
active compounds on the same relaxation pathway as
they are all inhibited by L-NAME and MB as have
not found any vasoconstricting compound among
the isolated metabolites of Fr. III. This suggests
stimulating NO generation as a main mechanism by
which Fr III as well as compounds 2, 4, and 5 in-
duce vasodilation. The NO generation measurement
in the present work reinforced this assumption as Fr.
III generated nitric oxide from isolated vessels even
better than acetylcholine (standard endothelial NO
generator). The same was true for vasorelaxation ac-
tivity. In addition, compounds 2, 4, and 5 generated
nitric oxide to a level comparable to acetylcholine.
The ability of flavonoid nucleus as in 2 to stimulate
NO generation was previously reported [9], mean-
while; benzophenone nucleus in 4 is reported here for
the first time for this activity. Furthermore, epicate-
chin (5) (flavanol nucleus) was known for its vasore-
laxant activity through increasing NO levels in the
vasculature [35, 36]. It was reported that the NO-
preserving activity of (−)-epicatechin on vascular
endothelial cells was due to inhibition of endothelial
NADPH oxidase activity [37].
The assumption that compounds 2, 4, and 5 are the
main active metabolites responsible for activity of Fr. III
and hence the total extract of GM was confirmed by the
observed alleviation of exaggerated vasoconstriction
when incubating them with MetS aortae for only thirty
minutes.
The involvement of ROS (endogenous or exogen-
ous) in vascular tone by acting as a mediator for sig-
nal transduction in endothelial cells was reported
before [34, 38, 39]. In this work, fructose was used to
induce MetS resulting in elevation of ROS as previ-
ously reported [40, 41]. Production of ROS in MetS
resulted in occurrence of different vascular diseases
which could be attributed to the ability of ROS to de-
crease bioavailability of NO and endothelial dysfunc-
tion. Moreover, ROS is responsible for vascular
diseases through its ability to produce many oxidized
and nitrated secondary metabolites [42]. In the
present study, Fr. III and compounds 4 and 5 sup-
pressed ROS in MetS aortae. This could also be one
of the mechanisms by which GM alleviated exagger-
ated vasoconstriction and induced vasodilation
through increasing NO bioavailability as a result of
inhibiting ROS.
Fig. 5 The effect of cumulative addition of Fr. III (1–10 μg/mL, a) and compounds (1–6, 10–100 μM, b and c) on phenylephrine (PE 10 μM) pre-contracted
isolated aortae. Nω-Nitro-L-arginine methyl ester hydrochloride (L-NAME, 100 μM), methylene blue (MB, 5 μM), tetraethylammonium chloride (TEA,
10 mM) and indomethacin (INDO, 5 μM) or the vehicle (0.1 % DMSO) were added 30 min before investigating the vasodilator effect.
*P < 0.05, compared with the corresponding control values; #P < 0.05, compared with the corresponding compound values; by Tow Way
ANOVA and Dunnett’s post hoc test
Fig. 6 The nitric oxide generating effect of Fr III (10 μg/mL) and
compounds (2, 4 & 5 at conc. 100 μM)) in aortae isolated from
normal animals *P < 0.05, compared with the corresponding
control values; by One Way ANOVA and Dunnett's Multiple
Comparison Test”
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Conclusion
GM significantly inhibited the exaggerated vasocon-
striction in MetS. Fr. III and isolated compounds 2,
4, and 5 are the most effective ones from the extracts
who are responsible for the observed activity through
vasodilatation-NO generation mechanism.
Additional file
Additional file 1: Supplementary document Table S1. NMR spectral
data of compounds 1–3, Table S2. NMR spectral data of compounds 4–6.
Figure S1-S12; 1H and 13C NMR data of compounds 1–6. (DOC 4189 kb)
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